期刊文献+

苯萘基糖苷类化合物的合成及其治疗糖尿病的活性 被引量:4

Synthesis and Anti-diabetic Activity of Phenylnaphthyl Glycosides
在线阅读 下载PDF
导出
摘要 以1,2-二甲氧基苯,丁二酸酐以及α-溴代四乙酰基吡喃糖为原料,设计并合成了作为SGLT2抑制剂的两个结构新颖的苯萘基糖苷化合物(6a和6b),其结构经1HNMR,13C NMR,IR和ESI-MS确认。利用小鼠体内葡萄糖耐受量法测定了6治疗糖尿病的活性,结果发现6a具有明显的降血糖作用,其活性与阳性对照药格列齐特相当。 Two novel phenylnaphthyl glycoside compounds (6a and 6b) were designed and synthesized as SGLT2 inhibitors from 1,2-dimethoxybenzene, succinic anhydride and tetra-O-acetyl-α-gly- copyranosyl bromides. The structures were characterized by 1H NMR, 13C NMR, IR and ESI-MS. Anti-diabetic activity was performed through in vivo by oral glucose tolerance test in mice. The preliminary pharmacological test of 6 showed that 6a was able to decrease blood glucose significantly using Gliclazide as a positive control drug.
出处 《合成化学》 CAS CSCD 北大核心 2009年第5期570-573,共4页 Chinese Journal of Synthetic Chemistry
基金 科技部支撑计划资助项目(2007BAI40B01)
关键词 SGLT2抑制剂 苯基萘 糖苷 合成 治疗糖尿病的活性 SGLT2 inhibitor phenylnaphthalene glycoside synthesis anti-diabetic activity
  • 相关文献

参考文献10

  • 1埃尔斯沃斯·B,沃什伯恩·W·N,谢尔·P·M,等.C-芳基葡糖苷SGLT2抑制剂和方法[P].CN03811353.8,2005.
  • 2德什潘德·P·P,埃尔斯沃斯·B·A,辛·J,赖·C,克里斯皮诺·G,等.制备C-芳基葡糖苷SGLT2抑制剂的方法[P].CN200380110040.1,2006.
  • 3沃什伯恩·W,孟巍.C-芳基葡糖苷SGLT2抑制剂和方法[P].CN200580040189.6,2007.
  • 4WASHBURN W N. O-glucosylated benzamide SGLT2 inhibitors and method[ P]. US 6 555 519,2003.
  • 5WASHBURN W N, SHER P M, WU G. O-aryl glucoside SGLT2 and method[P]. US 6 683 056,2004.
  • 6FUSHIMI N, FUJIKURA H, NISHIMURA T, et al. Glucopyranosyloxypyrazole derivatives and medicinal use thereof[ P]. US 7 294 618,2007.
  • 7TEANISHI H, KIKUCHI N, OHNO K. 1-(Glycopyranosyl )-3-subsituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof[ P]. EP 1 803 729,2007.
  • 8FRANCISCO C, KINNE R K H, WILHELM B, et al. Thioglycosides as pharmaceutically active agents [ P ]. EP 1 854 806,2007.
  • 9贾永林,李斌,邴柏春.2,3,4,6-四-O-乙酰基-1-巯基-吡喃葡萄糖的合成[J].化学与粘合,2007,29(3):189-192. 被引量:1
  • 10ZHAO G L, YU Z Y, LI Y, et al. Total synthesis of 4"-O-acetylmananthoside B part Ⅱ: Synthesis of the disaccharide fragment[ J ]. Chinese J Chem ,2008,26: 158 - 164.

二级参考文献8

同被引文献25

  • 1埃尔斯沃斯·B,沃什伯恩·w·N,谢尔·P·M.C.芳基葡糖苷SGLT2抑制剂和方法[P].CN03811353.8,2005.
  • 2Francisco C, Kinne R K H, Wilhelm B. Thioglycosides as pharmaceutically active agents [ P ]. EP 1 854 806, 2007.
  • 3Meng W, Ellsworth B A, Nirschl A A, et al. Discovery of dapaglitlozin : A potent, selective renal sodiumdependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 ciabetes[J]. J Med Chem, 2008,51 : 1145 - 1149.
  • 4唐章勇,唐灿.醛糖还原酶抑制剂筛选的研究进展[J].中国新药杂志,2007,16(19):1557-1560. 被引量:4
  • 5William N W. Development of the renal glucose reabsorption inhibitors: A new mechanism for the pharmacotherapy of diabetes mellitus type 2 [J]. J Med Chem, 2009, 52(7): 1785-1794.
  • 6Suk Y K, Min J K, Jinhwa L. 1, 2, 4-Triazinylmethyl-phenyl glucoside as novel C-aryl glucoside SGLT2 inhibitors [J]. Bull Korean Chem Soc, 2011, 32(8): 2938-2940.
  • 7Han S P, Hagan D L, Taylor J R, et al. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats [J]. Diabetes, 2008, 57(6): 1723-1729.
  • 8Zhang W B, Welihinda A, Mechanic J, et al. EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbAlc leves in db/db mice and prolongs the surval of stroke-prone rats [J]. Pharmacol Res, 2011, 63(4): 284-293.
  • 9Cole P, Vicente M, Castaner R, et al. Dapagliflozin [J]. Drugs Future, 2008, 33(9): 745-751.
  • 10Boldys A, Okopien B. Inhibitors of type 2 sodium glucose cotransporters-a new strategy for diabetes treatment [J]. Pharmacol Rep, 2009, 61(5): 778-784.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部